Información de la revista
Vol. 59. Núm. 1.
Páginas 117-121 (Julio 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 59. Núm. 1.
Páginas 117-121 (Julio 2003)
DOI: 10.1016/S1695-4033(03)78163-6
Acceso a texto completo
Dieta vegetariana en aciduria glutárica tipo I
Vegetarian diet in glutaric aciduria type I
Visitas
...
M.aC Carrascosa Romeroa,
Autor para correspondencia
rruiz@servitel.es

Correspondencia: Urbanización Pinares del Júcar, parcela 98. 02280 Villar de Pozo Rubio. Albacete. España.
, L. Abad Ortizb, I. Cuartero del Pozoc, R. Ruiz Canoc, R. Tébar Gilc
a Sección de Neuropediatría. Servicios de. Hospital General Universitario de Albacete. España.
b Radiodiagnóstico. Hospital General Universitario de Albacete. España.
c Pediatría. Hospital General Universitario de Albacete. España.
Información del artículo

La aciduria glutárica tipo I es una enfermedad neurometabólica, de herencia autosómico recesiva (1 caso/ 30.000), caracterizada por discinesia y distonía progresiva en niños, patológicamente por degeneración estriatal, en particular de los núcleos caudado y putamen, y bioquímicamente por deficiencia en tejidos de glutarilCoA deshidrogenasa, con cifras usualmente elevadas de ácidos glutárico y betahidroxiglutárico en orina. Actualmente no se considera una enfermedad tratable, puesto que al diagnóstico del paciente suele haber lesiones irreversibles en sistema nervioso central, beneficiándose del tratamiento los niños presintomáticos y, en general, los hermanos de otros pacientes ya diagnosticados.

Se presenta un niño de 23 meses con macrocefalia y mínimas manifestaciones neurológicas al diagnóstico, atribuidas a que el niño seguía una dieta semivegetariana. El establecimiento dietético y suplementos vitamínicos ha detenido e incluso mejorado la progresión sintomática de la enfermedad. Se concluye que a todo niño con macrocefalia progresiva de etiología no filiada se le debe realizar estudio de aminoácidos y ácidos orgánicos en orina para descartar aciduria glutárica tipo I.

Palabras clave:
Aciduria glutírica tipo I
Deficiencia glutaril-CoA deshidrogenasa
Macrocefalia
Síndrome distónico-discinético
Necrosis estriatal
necrosis estriatal
Imágenes RM

Glutaric aciduria type I is an autosomal recessive metabolic disease (1 case/30,000) characterized by a progressive dystonic-diakinetic syndrome in children. Pathologic examination reveals striatal degeneration of the caudate and putamen nucleus and biochemical analysis shows glutaryl CoA dehydrogenase deficiency. Values of glutaric and β-hydroxyglutaric acids in urine are usually increased. Currently, the disease is considered untreatable since there are usually irreversible lesions in the central nervous system at diagnosis. However, treatment can be provided to presymptomatic children and usually to the siblings of patients with this diagnosis.

We present the case of a 23-month-old boy, with macrocephaly and minimal neurologic manifestations at diagnosis, which were attributed to his semivegetarian diet. A dietary regimen and vitamin supplementation halted and even improved symptomatic progression of the disease. We conclude that amino and organic acids in urine should be investigated in all children with progressive macrocephaly of unknown etiology to rule out glutaric aciduria type I.

Keywords:
Glutaric aciduria type I
Glutaryl CoA dehydrogenase deficiency
Macrocephaly
Dystonic-dyskinetic syndrome
Vegetarian diet
Striatal necrosis
Magnetic resonance images
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.I. Goodman, S.P. Markey, P.G. Moe, B.S. Milles, C.C. Tenn.
Glutaric aciduria a "new" disorder of amino acid metabolism.
Biochem Med, 12 (1975), pp. 12-21
[2.]
S.I. Goodman, J.G. Kohlhoff.
Glutaric aciduria: Inherited defi-ciency of glutaril-CoA dehydrogenase activity.
Biochem Med, 13 (1975), pp. 138-140
[3.]
G.H. Hoffmann.
Glutaric aciduria type I and related cerebral organic acid disorders.
Inborn metabolic diseases: Diagnosis and treatment, 2nd ed, pp. 229-236
[4.]
S.I. Goodman, L.E. Kratz, G. Isaya, F.E. Frerman.
Cloning of gluta-ril-CoA dehydrogenase cDNA, and expression of wild type and mutant enzymes inEscherichia coli.
Hum Mol Genet, 4 (1995), pp. 1493-1498
[5.]
M. Schwartz, E. Christensen, A. Superti-Furga, N.J. Brandt.
The human glutaryl CoA dehydrogenase gene: Report of intronic sequence and of 13 novel mutations causing glutaric aciduria tipe.
Hum Genet, 102 (1998), pp. 452-458
[6.]
D.H. Morton, M.J. Bennet, L.E. Seargeant, L.A. Nichter, R.I. Kelley.
Glutaric aciduria tipe I: A common cause of episodic encepha-lopthy and spastic paralysis in the Amish of Lancaster country, Pensylvania.
Am J Med Gen, 41 (1991), pp. 89-95
[7.]
S.I. Goodman, F.E. Frerman.
Organic Acidemias due to defects in L ysine Oxidation: 2-Ketoadipic Acidemia and Glutaric Acide-mia.
6th ed, pp. 1451-1460
[8.]
G.F. Hoffmann, S. Athanassopoulos, A.B. Burlina, M. Duran, J.B.C. De Klerk, W. Lehnert, et al.
Clinical course, early diagnosis, and prevention of disease in glutaril-CoA dehydrogenase deficiency.
Neuropediatrics, 27 (1996), pp. 115-123
[9.]
J. Campistol, A. Ribes, L.L. Alvarez, E. Christensen, D.S. Millington.
Glutaric aciduria type I: Unusual biochemical presentation.
J Pediatr, 121 (1992), pp. 83-86
[10.]
A. Superti-Furga, G.H. Hoffman.
Glutaric aciduria tipe I (Glutaryl-CoA Dehydrogenase deficiency): Advances and unanaswered questions. Report fron an international meeting.
Eur J Pediatr, 156 (1997), pp. 821-828
[11.]
R. Ziadeh, E.W. Naylor, D. Fibegold.
Identification of two cases of glutaric aciduria type I through routine neonatal screening using liquid secondary ionization tandem mass spectrometry (abstract).
Book of The 6th International Congress on Inborn Errors of Metabolism, Milano, (May 1994), pp. pW 5.2
[12.]
S.I. Goodman, D.E. Stein, S. Schlesinger, E. Christensen, M. Schwartz, C.R. Greenberg, et al.
Glutaryl-CoA dehydrogenase mutation in glutaric acidemia (type I): Review and report of thirty novel mutations.
Hum Genet, 4 (1998), pp. 452-458
[13.]
B. Busquets, Merinero, E. Christensen, J. Gelpi, J. Campistol, M. Pineda, et al.
Glutaryl-CoA dehydrogenase deficiency in Spain: Evidence of two groups of patients, genetically and biochemically distinct.
Pediatric Research, 48 (2000), pp. 315-322
[14.]
L. Capa, J.L. Herranz, R. Arteaga, A. Abadi.
Necrosis estriatal bilateral infantil.
An Esp Pediatr, 35 (1991), pp. 55-58
[15.]
J.M. Prats Viñas, M.A. Ribes Rubio, M.P. Briones Godino, C. Garaizar Axpe, P. Sanjurjo Crespo.
Aciduria glutárica tipo.
An Esp Pediatr, 4 (1993), pp. 343-347
[16.]
A.K. Lafolla, S.G. Kahler.
Megalencephaly in the neonatal period as initial manifestation of glutaric aciduria tipo.
J Pediatr, 114 (1989), pp. 1004-1006
[17.]
J.M.a Prats Viñas.
Diagnóstico y tratamiento de las enfermedades metabólicas hereditarias, pp. 257-262
[18.]
J.C. Haworth, F.A. Booth, A.E. Chudley.
Phenotipic variability in glutaric aciduria type I: Report of fourteen cases in five canadian indian kindreds.
J Peddiatr, 118 (1991), pp. 52-58
[19.]
J. Aicardi, F. Goutieres, J.M. Saudubray, H. Ogier.
CT scans of infants with glutaric aciduria type.
J Peddiatr, 114 (1989), pp. 1004-1006
[20.]
S. Yamaguchi, T. Oriit, K. Yasuda, Yoshinorik.
Chronic subdural hematoma as an initial manifestation of glutaric aciduria type I.
Brain Dev, 15 (1993), pp. 125-127
Copyright © 2003. Asociación Española de Pediatría
Idiomas
Anales de Pediatría

Suscríbase a la newsletter

Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.